Medium impact
Teplizumab-mzwv (Tzield) (CPB 1022, reviewed 2025-12-03)
Aetna·Effective Dec 3, 2025
CPT 86341 is referenced in 1 tracked payer policy change from Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for CPT 86341 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.